Skip to main content
Market icon

Alamar Biosciences IPO Closing Market Cap

Market icon

Alamar Biosciences IPO Closing Market Cap

1.1B–1.2B 40%

0.9B–1.0B 39%

1.0B–1.1B 39.3%

1.3B+ 37%

Polymarket
नया

1.1B–1.2B 40%

0.9B–1.0B 39%

1.0B–1.1B 39.3%

1.3B+ 37%

Polymarket
नया

<0.9B

$112 वॉल्यूम

3%

0.9B–1.0B

$0 वॉल्यूम

39%

1.0B–1.1B

$51 वॉल्यूम

39%

1.1B–1.2B

$0 वॉल्यूम

40%

1.2B–1.3B

$0 वॉल्यूम

36%

1.3B+

$0 वॉल्यूम

37%

No IPO before June 2026

$0 वॉल्यूम

24%

This market will resolve based on Alamar Biosciences’ market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page. If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket. The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading. In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.

This market will resolve based on Alamar Biosciences’ market capitalization at the closing price on its first day of trading.

As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026".

Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency.

It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day.

If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently.

The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page.

If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket.

The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading.

In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.
वॉल्यूम
$163
समाप्ति तिथि
17 अप्रैल, 2026
बाज़ार खुला
Apr 14, 2026, 5:05 PM ET
This market will resolve based on Alamar Biosciences’ market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page. If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket. The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading. In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.
This market will resolve based on Alamar Biosciences’ market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page. If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket. The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading. In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.

This market will resolve based on Alamar Biosciences’ market capitalization at the closing price on its first day of trading.

As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026".

Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency.

It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day.

If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently.

The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page.

If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket.

The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading.

In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.
वॉल्यूम
$163
समाप्ति तिथि
17 अप्रैल, 2026
बाज़ार खुला
Apr 14, 2026, 5:05 PM ET
This market will resolve based on Alamar Biosciences’ market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on April 17 (ET). If no such IPO occurs by May 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before June 2026". Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day. If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently. The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page. If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket. The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading. In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.

बाहरी लिंक से सावधान रहें।

अक्सर पूछे जाने वाले प्रश्न

"Alamar Biosciences IPO Closing Market Cap" Polymarket पर 7 संभावित परिणामों वाला एक प्रेडिक्शन मार्केट है। वर्तमान में, 0.9B–1.0B 40% (40¢¢ प्रति शेयर) की implied probability के साथ आगे है, उसके बाद 1.1B–1.2B 40% पर है।

"Alamar Biosciences IPO Closing Market Cap" Polymarket पर एक नवनिर्मित बाज़ार है, Apr 14, 2026 को लॉन्च किया गया। एक शुरुआती बाज़ार के रूप में, यह पहले ट्रेडरों में शामिल होने और संभावनाएँ सेट करने और बाज़ार के शुरुआती मूल्य संकेत स्थापित करने का आपका अवसर है। आप समय के साथ बाज़ार की गति बढ़ने पर वॉल्यूम और ट्रेडिंग गतिविधि को ट्रैक करने के लिए इस पेज को बुकमार्क भी कर सकते हैं।

"Alamar Biosciences IPO Closing Market Cap" पर ट्रेड करने के लिए, इस पेज पर सूचीबद्ध 7 उपलब्ध परिणाम ब्राउज़ करें। प्रत्येक परिणाम बाज़ार की निहित संभावना को दर्शाने वाली वर्तमान कीमत प्रदर्शित करता है। पोजीशन लेने के लिए, वह परिणाम चुनें जो आपको सबसे संभावित लगता है, उसके पक्ष में ट्रेड करने के लिए "हाँ" या विरुद्ध ट्रेड करने के लिए "नहीं" चुनें, अपनी राशि दर्ज करें, और "ट्रेड" पर क्लिक करें।

"Alamar Biosciences IPO Closing Market Cap" के लिए वर्तमान प्रबल दावेदार "0.9B–1.0B" 40% पर है। निकटतम परिणाम "1.1B–1.2B" 40% पर है। ये संभावनाएँ रियल-टाइम में अपडेट होती हैं जैसे-जैसे ट्रेडर शेयर खरीदते और बेचते हैं।

"Alamar Biosciences IPO Closing Market Cap" के समाधान नियम ठीक-ठीक परिभाषित करते हैं कि प्रत्येक परिणाम को विजेता घोषित करने के लिए क्या होना चाहिए — जिसमें परिणाम निर्धारित करने के लिए उपयोग किए गए आधिकारिक डेटा स्रोत शामिल हैं। आप इस पेज पर टिप्पणियों के ऊपर "नियम" अनुभाग में पूर्ण समाधान मानदंड की समीक्षा कर सकते हैं।